Home › NDC Lookup › RxCUI directory › RxCUI 967017

Imiquimod 37.5 MG/ML Topical Cream — RxCUI 967017

Name: Imiquimod 37.5 MG/ML Topical Cream (RxCUI 967017)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 967017 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI967017

Official nameImiquimod 37.5 MG/ML Topical Cream

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asimiquimod 3.75 % Topical Cream

FDA products mapped6

Package NDCs mapped8

Reported Medicaid activity (SDUD)610 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Imiquimod Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Imiquimod 5% cream treats actinic keratosis on the face or scalp, certain superficial basal cell carcinomas, and external genital or perianal warts. Which one you use it for decide...
Wash the area with mild soap and let it dry. Put the cream on before bed and rub it in until it vanishes. Wash it off with mild soap and water after the recommended hours. Wash you...
Yes, local skin reactions are very common. Expect redness, itching, burning, flaking and crusting. If the skin weeps, breaks open, or you feel flu-like, call your doctor. A rest pe...
Is it normal for my skin to get red and sore?

📖 Read our full Imiquimod Topical guide →

🕸️ Concept Web — How Imiquimod 37.5 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Imiquimod 37.5 MG/ML Topical Cream RxCUI 967017 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Imiquimod 59943 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Zyclara 967018 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Imiquimod Topical Cream 378638 SCDF
- Imiquimod Topical Product 1160686 SCDG
- Imiquimod Topical Cream [Zyclara] 967020 SBDF
- Zyclara Topical Product 1186479 SBDG
- Topical Cream 316982 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Imiquimod 37.5 MG/ML 967016 SCDC
- Imiquimod 37.5 MG/ML Topical Cream [Zyclara] 967021 SBD
- Imiquimod 37.5 MG/ML [Zyclara] 967019 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Imiquimod 37.5 MG/ML SCDC · 967016
Imiquimod Topical Cream SCDF · 378638
Imiquimod Topical Product SCDG · 1160686

Brand-Name Concepts

Imiquimod 37.5 MG/ML Topical Cream [Zyclara] SBD · 967021
Imiquimod 37.5 MG/ML [Zyclara] SBDC · 967019
Imiquimod Topical Cream [Zyclara] SBDF · 967020
Zyclara Topical Product SBDG · 1186479
Zyclara BN · 967018

📦 FDA Products & Package NDCs

6 products · 8 package NDCs

8 package NDCs map to RxCUI 967017 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00093-3133-31	1 BOTTLE, PUMP in 1 CARTON (0093-3133-31) / 7.5 g in 1 BOTT...	Imiquimod	Teva Pharmaceuticals USA, Inc.	2020-07-30
51672-4174-06	28 PACKET in 1 CARTON (51672-4174-6) / .25 g in 1 PACKET (5...	Imiquimod	Sun Pharmaceutical Industries, Inc.	2021-01-26
51672-4174-09	1 BOTTLE, PUMP in 1 CARTON (51672-4174-9) / 7.5 g in 1 BOTT...	Imiquimod	Sun Pharmaceutical Industries, Inc.	2021-10-14
68682-0272-75	1 BOTTLE, PUMP in 1 CARTON (68682-272-75) / 7.5 g in 1 BOTT...	Imiquimod	Oceanside Pharmacueticals	2018-06-27
99207-0270-01	4 PACKET in 1 CARTON (99207-270-01) / .25 g in 1 PACKET	Zyclara	Bausch Health US, LLC	2011-11-28
99207-0271-01	1 BOTTLE, PUMP in 1 CARTON (99207-271-01) / 7.5 g in 1 BOTT...	Zyclara	Bausch Health US, LLC	2012-01-01
99207-0271-75	1 BOTTLE, PUMP in 1 CARTON (99207-271-75) / 7.5 g in 1 BOTT...	Zyclara	Bausch Health US, LLC	2012-01-01
99207-0276-01	1 BOTTLE, PUMP in 1 CARTON (99207-276-01) / 7.5 g in 1 BOTT...	Zyclara	Bausch Health US, LLC	2012-02-29

Observed labelers: Bausch Health US, LLC (4) · Sun Pharmaceutical Industries, Inc. (2) · Oceanside Pharmacueticals (1) · Teva Pharmaceuticals USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.